Improvement of Imiquimod Solubilization and Skin Retention via TPGS Micelles: Exploiting the Co-Solubilizing Effect of Oleic Acid

Imiquimod (IMQ) is an immunostimulant drug approved for the topical treatment of actinic keratosis, external genital-perianal warts as well as superficial basal cell carcinoma that is used off-label for the treatment of different forms of skin cancers, including some malignant melanocytic proliferat...

Full description

Bibliographic Details
Main Authors: Martina Ghezzi, Silvia Pescina, Andrea Delledonne, Ilaria Ferraboschi, Cristina Sissa, Francesca Terenziani, Paula De Freitas Rosa Remiro, Patrizia Santi, Sara Nicoli
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/9/1476
_version_ 1797517553561501696
author Martina Ghezzi
Silvia Pescina
Andrea Delledonne
Ilaria Ferraboschi
Cristina Sissa
Francesca Terenziani
Paula De Freitas Rosa Remiro
Patrizia Santi
Sara Nicoli
author_facet Martina Ghezzi
Silvia Pescina
Andrea Delledonne
Ilaria Ferraboschi
Cristina Sissa
Francesca Terenziani
Paula De Freitas Rosa Remiro
Patrizia Santi
Sara Nicoli
author_sort Martina Ghezzi
collection DOAJ
description Imiquimod (IMQ) is an immunostimulant drug approved for the topical treatment of actinic keratosis, external genital-perianal warts as well as superficial basal cell carcinoma that is used off-label for the treatment of different forms of skin cancers, including some malignant melanocytic proliferations such as lentigo maligna, atypical nevi and other in situ melanoma-related diseases. Imiquimod skin delivery has proven to be a real challenge due to its very low water-solubility and reduced skin penetration capacity. The aim of the work was to improve the drug solubility and skin retention using micelles of d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS), a water-soluble derivative of vitamin E, co-encapsulating various lipophilic compounds with the potential ability to improve imiquimod affinity for the micellar core, and thus its loading into the nanocarrier. The formulations were characterized in terms of particle size, zeta potential and stability over time and micelles performance on the skin was evaluated through the quantification of imiquimod retention in the skin layers and the visualization of a micelle-loaded fluorescent dye by two-photon microscopy. The results showed that imiquimod solubility strictly depends on the nature and concentration of the co-encapsulated compounds. The micellar formulation based on TPGS and oleic acid was identified as the most interesting in terms of both drug solubility (which was increased from few µg/mL to 1154.01 ± 112.78 µg/mL) and micellar stability (which was evaluated up to 6 months from micelles preparation). The delivery efficiency after the application of this formulation alone or incorporated in hydrogels showed to be 42- and 25-folds higher than the one of the commercial creams.
first_indexed 2024-03-10T07:18:08Z
format Article
id doaj.art-37e1f171fe724b4095a18264ec6d3afb
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T07:18:08Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-37e1f171fe724b4095a18264ec6d3afb2023-11-22T14:48:21ZengMDPI AGPharmaceutics1999-49232021-09-01139147610.3390/pharmaceutics13091476Improvement of Imiquimod Solubilization and Skin Retention via TPGS Micelles: Exploiting the Co-Solubilizing Effect of Oleic AcidMartina Ghezzi0Silvia Pescina1Andrea Delledonne2Ilaria Ferraboschi3Cristina Sissa4Francesca Terenziani5Paula De Freitas Rosa Remiro6Patrizia Santi7Sara Nicoli8Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, ItalyDepartment of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, ItalyDepartment of Chemistry, Life Science and Environmental Sustainability, University of Parma, Parco Area delle Scienze 17/A, 43124 Parma, ItalyDepartment of Chemistry, Life Science and Environmental Sustainability, University of Parma, Parco Area delle Scienze 17/A, 43124 Parma, ItalyDepartment of Chemistry, Life Science and Environmental Sustainability, University of Parma, Parco Area delle Scienze 17/A, 43124 Parma, ItalyDepartment of Chemistry, Life Science and Environmental Sustainability, University of Parma, Parco Area delle Scienze 17/A, 43124 Parma, ItalyDepartment of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, ItalyDepartment of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, ItalyDepartment of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, ItalyImiquimod (IMQ) is an immunostimulant drug approved for the topical treatment of actinic keratosis, external genital-perianal warts as well as superficial basal cell carcinoma that is used off-label for the treatment of different forms of skin cancers, including some malignant melanocytic proliferations such as lentigo maligna, atypical nevi and other in situ melanoma-related diseases. Imiquimod skin delivery has proven to be a real challenge due to its very low water-solubility and reduced skin penetration capacity. The aim of the work was to improve the drug solubility and skin retention using micelles of d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS), a water-soluble derivative of vitamin E, co-encapsulating various lipophilic compounds with the potential ability to improve imiquimod affinity for the micellar core, and thus its loading into the nanocarrier. The formulations were characterized in terms of particle size, zeta potential and stability over time and micelles performance on the skin was evaluated through the quantification of imiquimod retention in the skin layers and the visualization of a micelle-loaded fluorescent dye by two-photon microscopy. The results showed that imiquimod solubility strictly depends on the nature and concentration of the co-encapsulated compounds. The micellar formulation based on TPGS and oleic acid was identified as the most interesting in terms of both drug solubility (which was increased from few µg/mL to 1154.01 ± 112.78 µg/mL) and micellar stability (which was evaluated up to 6 months from micelles preparation). The delivery efficiency after the application of this formulation alone or incorporated in hydrogels showed to be 42- and 25-folds higher than the one of the commercial creams.https://www.mdpi.com/1999-4923/13/9/1476imiquimodpolymeric micellesskin deliveryfatty acidssolubilityskin cancer
spellingShingle Martina Ghezzi
Silvia Pescina
Andrea Delledonne
Ilaria Ferraboschi
Cristina Sissa
Francesca Terenziani
Paula De Freitas Rosa Remiro
Patrizia Santi
Sara Nicoli
Improvement of Imiquimod Solubilization and Skin Retention via TPGS Micelles: Exploiting the Co-Solubilizing Effect of Oleic Acid
Pharmaceutics
imiquimod
polymeric micelles
skin delivery
fatty acids
solubility
skin cancer
title Improvement of Imiquimod Solubilization and Skin Retention via TPGS Micelles: Exploiting the Co-Solubilizing Effect of Oleic Acid
title_full Improvement of Imiquimod Solubilization and Skin Retention via TPGS Micelles: Exploiting the Co-Solubilizing Effect of Oleic Acid
title_fullStr Improvement of Imiquimod Solubilization and Skin Retention via TPGS Micelles: Exploiting the Co-Solubilizing Effect of Oleic Acid
title_full_unstemmed Improvement of Imiquimod Solubilization and Skin Retention via TPGS Micelles: Exploiting the Co-Solubilizing Effect of Oleic Acid
title_short Improvement of Imiquimod Solubilization and Skin Retention via TPGS Micelles: Exploiting the Co-Solubilizing Effect of Oleic Acid
title_sort improvement of imiquimod solubilization and skin retention via tpgs micelles exploiting the co solubilizing effect of oleic acid
topic imiquimod
polymeric micelles
skin delivery
fatty acids
solubility
skin cancer
url https://www.mdpi.com/1999-4923/13/9/1476
work_keys_str_mv AT martinaghezzi improvementofimiquimodsolubilizationandskinretentionviatpgsmicellesexploitingthecosolubilizingeffectofoleicacid
AT silviapescina improvementofimiquimodsolubilizationandskinretentionviatpgsmicellesexploitingthecosolubilizingeffectofoleicacid
AT andreadelledonne improvementofimiquimodsolubilizationandskinretentionviatpgsmicellesexploitingthecosolubilizingeffectofoleicacid
AT ilariaferraboschi improvementofimiquimodsolubilizationandskinretentionviatpgsmicellesexploitingthecosolubilizingeffectofoleicacid
AT cristinasissa improvementofimiquimodsolubilizationandskinretentionviatpgsmicellesexploitingthecosolubilizingeffectofoleicacid
AT francescaterenziani improvementofimiquimodsolubilizationandskinretentionviatpgsmicellesexploitingthecosolubilizingeffectofoleicacid
AT pauladefreitasrosaremiro improvementofimiquimodsolubilizationandskinretentionviatpgsmicellesexploitingthecosolubilizingeffectofoleicacid
AT patriziasanti improvementofimiquimodsolubilizationandskinretentionviatpgsmicellesexploitingthecosolubilizingeffectofoleicacid
AT saranicoli improvementofimiquimodsolubilizationandskinretentionviatpgsmicellesexploitingthecosolubilizingeffectofoleicacid